EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte Studie

A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer

Andrew M Baschnagel, Mattison J Flakus, Eric M Wallat, Antonia E Wuschner, Richard J Chappell, R Adam Bayliss, Randall J Kimple, Gary E Christensen, Joseph M Reinhardt, Michael F Bassetti, John E Bayouth

International Journal of Radiation Oncology*Biology*Physics · 2024-08 · 119 (5) · 1393-1402

DOI: 10.1016/j.ijrobp.2024.02.019 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-08. Verfasst von Andrew M Baschnagel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin. Electronic address: baschnagel@humonc.wisc.edu. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Four-Dimensional Computed Tomography, Lung Neoplasms, Lung. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NCI NIH HHS, National Institutes of Health, University of Wisconsin Carbone Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To determine whether 4-dimensional computed tomography (4DCT) ventilation-based functional lung avoidance radiation therapy preserves pulmonary function compared with standard radiation therapy for non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: This single center, randomized, phase 2 trial enrolled patients with NSCLC receiving curative intent radiation therapy with either stereotactic body radiation therapy or conventionally fractionated radiation therapy between 2016 and 2022. Patients were randomized 1:1 to standard of care radiation therapy or functional lung avoidance radiation therapy. The primary endpoint was the change in Jacobian-based ventilation as measured on 4DCT from baseline to 3 months postradiation. Secondary endpoints included changes in volume of high- and low-ventilating lung, pulmonary toxicity, and changes in pulmonary function tests (PFTs). RESULTS: A total of 122 patients were randomized and 116 were available for analysis. Median follow up was 29.9 months. Functional avoidance plans significantly (P < .05) reduced dose to high-functioning lung without compromising target coverage or organs at risk constraints. When analyzing all patients, there was no difference in the amount of lung showing a reduction in ventilation from baseline to 3 months between the 2 arms (1.91% vs 1.87%; P = .90). Overall grade ≥2 and grade ≥3 pulmonary toxicities for all patients were 24.1% and 8.6%, respectively. There was no significant difference in pulmonary toxicity or changes in PFTs between the 2 study arms. In the conventionally fractionated cohort, there was a lower rate of grade ≥2 pneumonitis (8.2% vs 32.3%; P = .049) and less of a decline in change in forced expiratory volume in 1 second (-3 vs -5; P = .042) and forced vital capacity (1.5 vs -6; P = .005) at 3 months, favoring the functional avoidance arm. CONCLUSIONS: There was no difference in posttreatment ventilation as measured by 4DCT between the arms. In the cohort of patients treated with conventionally fractionated radiation therapy with functional lung avoidance, there was reduced pulmonary toxicity, and less decline in PFTs suggesting a clinical benefit in patients with locally advanced NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungFour-Dimensional Computed TomographyLung NeoplasmsLungHumansMaleFemaleAgedMiddle AgedRadiosurgeryAged, 80 and overDose Fractionation, RadiationOrgan Sparing TreatmentsOrgans at RiskRespiratory Function TestsRespiration

Autor:innen und Institutionen

  • Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin. Electronic address: baschnagel@humonc.wisc.edu.
  • Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
  • Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin.
  • Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa.
  • Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • University of Wisconsin Carbone Cancer Center

Zitieren

APA

Baschnagel, A. M., Flakus, M. J., Wallat, E. M., Wuschner, A. E., Chappell, R. J., Bayliss, R. A., Kimple, R. J., Christensen, G. E., Reinhardt, J. M., Bassetti, M. F., & Bayouth, J. E. (2024). A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics, 119(5), 1393-1402. https://doi.org/10.1016/j.ijrobp.2024.02.019

Vancouver

Baschnagel AM, Flakus MJ, Wallat EM, Wuschner AE, Chappell RJ, Bayliss RA, et al. A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2024;119(5):1393-1402. doi:10.1016/j.ijrobp.2024.02.019

BibTeX
@article{Baschnagel2024,
  author = {Baschnagel, Andrew M and Flakus, Mattison J and Wallat, Eric M and Wuschner, Antonia E and Chappell, Richard J and Bayliss, R Adam and Kimple, Randall J and Christensen, Gary E and Reinhardt, Joseph M and Bassetti, Michael F and Bayouth, John E},
  title = {A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {5},
  pages = {1393--1402},
  doi = {10.1016/j.ijrobp.2024.02.019}
}
Kostenlos starten →